Towa Pharmaceutical Co Ltd
TSE:4553

Watchlist Manager
Towa Pharmaceutical Co Ltd Logo
Towa Pharmaceutical Co Ltd
TSE:4553
Watchlist
Price: 3 615 JPY 0.56% Market Closed
Market Cap: ¥178B

Net Margin

7.7%
Current
Improving
by 2.2%
vs 3-y average of 5.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.7%
=
Net Income
¥20.6B
/
Revenue
¥266.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.7%
=
Net Income
¥20.6B
/
Revenue
¥266.7B

Peer Comparison

Country Company Market Cap Net
Margin
JP
Towa Pharmaceutical Co Ltd
TSE:4553
178B JPY
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
560.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
287.9B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.3B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
296.3B USD
Loading...
CH
Novartis AG
SIX:NOVN
229.6B CHF
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
148.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
98.2B EUR
Loading...

Market Distribution

In line with most companies in Japan
Percentile
66th
Based on 6 917 companies
66th percentile
7.7%
Low
-122 700% — 2.9%
Typical Range
2.9% — 8.5%
High
8.5% — 63 031.4%
Distribution Statistics
Japan
Min -122 700%
30th Percentile 2.9%
Median 5.4%
70th Percentile 8.5%
Max 63 031.4%

Towa Pharmaceutical Co Ltd
Glance View

Market Cap
178B JPY
Industry
Pharmaceuticals

Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Kadoma-Shi, Osaka-Fu and currently employs 3,456 full-time employees. The company went IPO on 2004-04-05. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. The company is a drug with the same effect, usage and dosage. The firm is involved in the sale and outsourced manufacture of products and generic drugs. The firm is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The firm is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.

Intrinsic Value
7 497.61 JPY
Undervaluation 52%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
7.7%
=
Net Income
¥20.6B
/
Revenue
¥266.7B
What is Towa Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Towa Pharmaceutical Co Ltd is 7.7%, which is above its 3-year median of 5.5%.

How has Net Margin changed over time?

Over the last 3 years, Towa Pharmaceutical Co Ltd’s Net Margin has increased from 5.4% to 7.7%. During this period, it reached a low of 1.1% on Mar 31, 2023 and a high of 7.7% on Sep 30, 2025.

Back to Top